Mice Heterozygous for the Oxytocin Receptor Gene (Oxtr+/-) Show Impaired Social Behaviour but not Increased Aggression or Cognitive Inflexibility: Evidence of a Selective Haploinsufficiency Gene Effect

Journal of Neuroendocrinology

Volumn 25, Issue 2, 2013, Pages 107-118

  Sala, M ^a,b   Braida, D ^a   Donzelli, A ^a   Martucci, R ^a   Busnelli, M ^a,b   Bulgheroni, E ^b   Rubino, T ^c   Parolaro, D ^c   Nishimori, K ^d   Chini, B ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Behavioural phenotype; Oxytocin receptor; Selective agonists

Indexed keywords

GLYCINE; OXYTOCIN RECEPTOR; RELCOVAPTAN; THREONINE; VASOPRESSIN V1A RECEPTOR;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; AUTORADIOGRAPHY; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; GENE INACTIVATION; GENE LOSS; GENOTYPE; HAPLOINSUFFICIENCY; HETEROZYGOSITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR;

EID: 84873042521     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02385.x     Document Type: Article

References (50)

1. Barberis C, Morin D, Durroux T, Mouillac B, Guillon G, Seyer R, Hibert M, Tribollet E, Manning M. Molecular pharmacology of AVP and OT receptors and therapeutic potential. Drug News Perspect 1999; 12: 279-292.
2. Lee HJ, Macbeth AH, Pagani JH, Young WS III. Oxytocin: the great facilitator of life. Prog Neurobiol 2009; 88: 127-151.
3. Insel TR. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 2010; 65: 768-779.
4. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 2011; 12: 524-538.
5. Kuehn B. Scientists probe oxytocin therapy for social deficits in autism, schizophrenia. JAMA 2011; 305: 659-661.
6. Winslow JT, Insel TR. The social deficits of the oxytocin knockout mouse. Neuropeptides 2002; 36: 221-229.
7. Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk MM, Young LJ, Nishimori K. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci USA 2005; 102: 16096-16101.
8. Jin D, Liu HX, Hirai H, Torashima T, Nagai T, Lopatina O, Shnayder NA, Yamada K, Noda M, Seike T, Fujita K, Takasawa S, Yokoyama S, Koizumi K, Shiraishi Y, Tanaka S, Hashii M, Yoshihara T, Higashida K, Islam MS, Yamada N, Hayashi K, Noguchi N, Kato I, Okamoto H, Matsushima A, Salmina A, Munesue T, Shimizu N, Mochida S, Asano M, Higashida H. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 2007; 446: 41-45.
9. Birkett SD, Pickering BT. The vasopressin precursor in the Brattleboro (di/di) rat. Int J Pept Protein Res 1988; 32: 565-572.
10. Bielsky IF, Hu SB, Szegda KL, Westphal H, Young LJ. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 2004; 29: 483-493.
11. Stevenson EL, Caldwell HK. The vasopressin 1b receptor and the neural regulation of social behavior. Horm Behav 2012; 61: 277-282.
12. Sala M, Braida D, Lentini D, Busnelli M, Bulgheroni E, Capurro V, Finardi A, Donzelli A, Pattini L, Rubino T, Parolaro D, Nishimori K, Parenti M, Chini B. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry 2011; 69: 875-882.
13. Phelps SM, Campbell P, Zheng DJ, Ophir AG. Beating the boojum: comparative approaches to the neurobiology of social behavior. Neuropharmacology 2010; 58: 17-28.
14. Lee HJ, Caldwell HK, Macbeth AH, Tolu SG, Young WS III. A conditional knockout mouse line of the oxytocin receptor. Endocrinology 2008; 149: 3256-3263.
15. Macbeth AH, Lee HJ, Edds J, Young WS III. Oxytocin and the oxytocin receptor underlie intrastrain, but not interstrain, social recognition. Genes Brain Behav 2009; 8: 558-567.
16. Curley JP, Davidson S, Bateson P, Champagne FA. Social enrichment during postnatal development induces transgenerational effects on emotional and reproductive behavior in mice. Front Behav Neurosci 2009; 3: 25.
17. Carter CS. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders? Behav Brain Res 2007; 176: 170-186.
18. Fisher E, Scambler P. Human haploinsufficiency-one for sorrow, two for joy. Nat Genet 1994; 7: 5-7.
19. Watanabe Y, Kaida Y, Takechi K, Kamei C. Anticonvulsant effect of (RS)-1-aminoindan-1, 5-dicarboxylic acid on pentetrazol-induced kindled seizures in mice. Biol Pharm Bull 2010; 33: 647-652.
20. Franklin KB, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Academic Press Inc., Oxford, 2007.
21. Deacon RM. Assessing nest building in mice. Nat Protoc 2006; 1: 1117-1119.
22. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 1968; 13: 222-57.
23. Jero J, Coling DE, Lalwani AK. The use of preyer's reflex in evaluation of hearing in mice. Acta Otolaryngol 2001; 121: 585-589.
24. Brandewiede J, Schachner M, Morellini F. Ethological analysis of the senescence-accelerated P/8 mouse. Behav Brain Res 2005; 158: 109-121.
25. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004; 3: 287-302.
26. Dauge V, Sebret A, Beslot F, Matsui T, Roques BP. Behavioral profile of CCK2 receptor-deficient mice. Neuropsychopharmacology 2001; 25: 690-698.
27. Crawley JN. What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice New York, NY: Wiley-Liss, 2000.
28. File SE, Mahal A, Mangiarini L, Bates GP. Striking changes in anxiety in Huntington's disease transgenic mice. Brain Res 1998; 2: 234-240.
29. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92: 180-185.
30. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336.
31. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985; 85: 367-370.
32. Kalueff AV, Gallagher PS, Murphy DL. Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia. NeuroReport 2006; 17: 1347-1351.
33. DeVito LM, Konigsberg R, Lykken C, Sauvage M, Young WS III, Eichenbaum H. Vasopressin 1b receptor knock-out impairs memory for temporal order. J Neurosci 2009; 29: 2676-2683.
34. Tordjman S, Carlier M, Cohen D, Cesselin F, Bourgoin S, Colas-Linhart N, Petiet A, Perez-Diaz F, Hamon M, Roubertoux PL. Aggression and the three opioid families (endorphins, enkephalins, and dynorphins) in mice. Behav Genet 2003; 33: 529-536.
35. Francis DD, Young LJ, Meaney MJ, Insel TR. Naturally occurring differences in maternal care are associated with the expression of oxytocin and vasopressin (V1a) receptors: gender differences. J Neuroendocrinol 2002; 14: 349-353.
36. Rubino T, Forlani G, Vigano D, Zippel R, Parolaro D. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects. J Neurochem 2005; 93: 984-991.
37. Chini B, Manning M. Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges. Biochem Soc Trans 2007; 4: 737-741.
38. Chini B, Manning M, Guillon G. Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an 'easy guide' to receptor pharmacology. Prog Brain Res 2008; 170: 513-517.
39. Lowbridge J, Manning M, Haldar J, Sawyer WH. Synthesis and some pharmacological properties of [4-threonine, 7-glycine]-oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]-oxytocin, and [7-glycine]-oxytocin: peptides with high oxytocic/antidiuretic selectivity. J Med Chem 1977; 20: 120-123.
40. Huber D, Veinante P, Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005; 308: 245-248.
41. Gozzi A, Jain A, Giovanelli A, Bertollini C, Crestan V, Schwarz AJ, Tsetsenis T, Ragozzino D, Gross CT, Bifone A. A neural switch for active and passive fear. Neuron 2010; 67: 656-666.
42. Braida D, Donzelli A, Martucci R, Capurro V, Busnelli M, Chini B, Sala M. Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish. Psychopharmacology(Berl) 2012; 220: 319-330.
43. Ross HE, Young LJ. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front Neuroendocrinol 2009; 30: 534-547.
44. Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, Markunas CA, Lintas C, Abramson RK, Wright HH, Ellis P, Langford CF, Worley G, Delong GR, Murphy SK, Cuccaro ML, Persico A, Pericak-Vance MA. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 2009; 7: 62.
45. Liu W, Pappas GD, Carter CS. Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/-) reeler mice. Neurol Res 2005; 27: 339-345.
46. Teixeira CM, Martin ED, Sahun I, Masachs N, Pujadas L, Corvelo A, Bosch C, Rossi D, Martinez A, Maldonado R, Dierssen M, Soriano E. Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder. Neuropsychopharmacology 2011; 36: 2395-2405.
47. Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T, Nishimori K. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci 2009; 29: 2259-2271.
48. Eaton JL, Roache L, Nguyen KN, Cushing BS, Troyer E, Papademetriou E, Raghanti MA. Organizational effects of oxytocin on serotonin innervation. Dev Psychobiol 2012; 54: 92-97.
49. Baskerville TA, Douglas AJ. Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci Ther 2010; 16: e92-e123.
50. Popik P, Vetulani J, Van Ree JM. Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides. Eur J Pharmacol 1996; 308: 113-116.